Here are the latest new cancer drugs approved by the Food and Drug Administration:

  • Exkivity (mobocertinib) for advanced non-small-cell lung cancer
  • Scemblix (asciminib) for chronic myeloid leukemia
  • Tivdak (tisotumab vedotin) for advanced cervical cancer
  • Welireg (belzutifan) for Von Hippel-Lindau syndrome